Lista de obras -

A Randomized Trial of a Low-Trapping Nonselective N-Methyl-D-Aspartate Channel Blocker in Major Depression ⬇️

artículo científico publicado el 15 de agosto de 2013

A Randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorder

artículo científico publicado en 2012

A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression

artículo científico publicado en 2010

A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression.

scientific article published on 04 January 2016

A single infusion of ketamine improves depression scores in patients with anxious bipolar depression

artículo científico publicado en 2014

Abnormal hippocampal functioning and impaired spatial navigation in depressed individuals: evidence from whole-head magnetoencephalography

artículo científico publicado en 2010

Acute stress symptoms do not worsen in posttraumatic stress disorder and abuse with a single subanesthetic dose of ketamine

artículo científico publicado en 2012

Amygdala volume in depressed patients with bipolar disorder assessed using high resolution 3T MRI: the impact of medication

artículo científico publicado en 2009

An investigation of amino-acid neurotransmitters as potential predictors of clinical improvement to ketamine in depression

artículo científico publicado en 2011

An open-label trial of riluzole in patients with treatment-resistant major depression

artículo científico publicado en 2004

Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials.

artículo científico publicado en 2017

Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant.

artículo científico publicado en 2015

Baseline delta sleep ratio predicts acute ketamine mood response in major depressive disorder ⬇️

artículo científico publicado el 5 de agosto de 2012

Baseline working memory activation deficits in dimensional anxious depression as detected by magnetoencephalography ⬇️

artículo científico publicado en 2015

Biomarkers in mood disorders research: developing new and improved therapeutics

artículo científico publicado en 2014

Brain-derived neurotrophic factor Val66Met polymorphism and antidepressant efficacy of ketamine in depressed patients.

artículo científico publicado en 2012

Brain-derived neurotrophic factor and initial antidepressant response to an N-methyl-D-aspartate antagonist.

artículo científico publicado en 2009

Clinical predictors of ketamine response in treatment-resistant major depression

artículo científico publicado en 2014

Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder

artículo científico publicado en 2012

Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study

artículo científico publicado en 2012

D-serine plasma concentration is a potential biomarker of (R,S)-ketamine antidepressant response in subjects with treatment-resistant depression

artículo científico publicado en 2014

Default Mode Connectivity in Major Depressive Disorder Measured Up to 10 Days After Ketamine Administration

scholarly article by Jennifer W Evans et al published 15 October 2018 in Biological Psychiatry

Defining anxious depression: a review of the literature.

artículo científico publicado en 2013

Developing biomarkers in mood disorders research through the use of rapid-acting antidepressants

artículo científico publicado en 2014

Do the dissociative side effects of ketamine mediate its antidepressant effects?

artículo científico publicado en 2014

Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine.

artículo científico

Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study

artículo científico publicado en 2007

Family history of alcohol dependence and antidepressant response to an N‐methyl‐D‐aspartate antagonist in bipolar depression ⬇️

artículo científico publicado el 14 de septiembre de 2012

Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonist

artículo científico publicado en 2008

Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression.

artículo científico publicado en 2018

Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder

artículo científico publicado en 2013

Glutamatergic modulators: the future of treating mood disorders?

artículo científico publicado en 2010

Histone deacetylases and mood disorders: epigenetic programming in gene-environment interactions

artículo científico publicado en 2010

Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety.

artículo científico publicado en 2014

Increased fear-potentiated startle in major depressive disorder patients with lifetime history of suicide attempt

artículo científico publicado en 2014

Ketamine's antidepressant efficacy is extended for at least four weeks in subjects with a family history of an alcohol use disorder.

artículo científico publicado en 2014

Lithium and Valproate Levels Do Not Correlate with Ketamine's Antidepressant Efficacy in Treatment-Resistant Bipolar Depression

artículo científico publicado en 2015

Major Depression Is Not Associated with Blunting of Aversive Responses; Evidence for Enhanced Anxious Anticipation ⬇️

artículo científico publicado el 8 de agosto de 2013

Motor-Activity Markers of Circadian Timekeeping Are Related to Ketamine's Rapid Antidepressant Properties

artículo científico publicado en 2017

NEUROBIOLOGICAL ASPECTS OF SUICIDE AND SUICIDE ATTEMPTS IN BIPOLAR DISORDER.

artículo científico publicado en 2013

Neural correlates of rapid antidepressant response to ketamine in bipolar disorder.

artículo científico publicado en 2013

Neural correlates of rapid antidepressant response to ketamine in treatment-resistant unipolar depression: a preliminary positron emission tomography study.

artículo científico publicado en 2013

Neurobiology of anxious depression: a review

artículo científico publicado en 2013

New therapeutic targets for mood disorders

artículo científico publicado en 2010

Novel glutamatergic agents for major depressive disorder and bipolar disorder

artículo científico publicado en 2011

Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effects

artículo científico publicado en 2010

Pharmacologic treatment of dimensional anxious depression: a review

artículo científico publicado en 2014

Pramipexole for bipolar II depression: a placebo-controlled proof of concept study

artículo científico publicado en 2004

Protein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorder

artículo científico publicado en 2009

Rapid antidepressant changes with sleep deprivation in major depressive disorder are associated with changes in vascular endothelial growth factor (VEGF): a pilot study

artículo científico publicado en 2011

Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression

artículo científico publicado en 2011

Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder

artículo científico publicado en 2010

Rating depression over brief time intervals with the Hamilton Depression Rating Scale: standard vs. abbreviated scales

artículo científico publicado en 2014

Recognition of emotional facial expressions in anxious and nonanxious depression.

artículo científico publicado en 2016

Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression

artículo científico publicado en 2012

Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial

artículo científico publicado en 2012

Riluzole likely lacks antidepressant efficacy in ketamine non-responders.

artículo científico publicado en 2014

Second messenger/signal transduction pathways in major mood disorders: moving from membrane to mechanism of action, part I: major depressive disorder.

artículo científico publicado en 2013

Second messenger/signal transduction pathways in major mood disorders: moving from membrane to mechanism of action, part II: bipolar disorder

artículo científico publicado en 2013

Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression

artículo científico publicado en 2012

Subanesthetic Dose Ketamine Does Not Induce an Affective Switch in Three Independent Samples of Treatment-Resistant Major Depression ⬇️

artículo científico publicado el 28 de mayo de 2013

Synaptic Potentiation Is Critical for Rapid Antidepressant Response to Ketamine in Treatment-Resistant Major Depression ⬇️

artículo científico publicado el 21 de abril de 2012

Targeting glutamatergic signaling for the development of novel therapeutics for mood disorders

scientific article published on January 2009

The McLean-Harvard First-Episode Mania Study: Prediction of Recovery and First Recurrence

artículo científico publicado en 2003

The Neurobiology of the Switch Process in Bipolar Disorder

artículo científico publicado en 2010

Lista de obras de

A Randomized Trial of a Low-Trapping Nonselective N-Methyl-D-Aspartate Channel Blocker in Major Depression ⬇️

A Randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorder

A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression

A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression.

A single infusion of ketamine improves depression scores in patients with anxious bipolar depression

Abnormal hippocampal functioning and impaired spatial navigation in depressed individuals: evidence from whole-head magnetoencephalography

Acute stress symptoms do not worsen in posttraumatic stress disorder and abuse with a single subanesthetic dose of ketamine

Amygdala volume in depressed patients with bipolar disorder assessed using high resolution 3T MRI: the impact of medication

An investigation of amino-acid neurotransmitters as potential predictors of clinical improvement to ketamine in depression

An open-label trial of riluzole in patients with treatment-resistant major depression

Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials.

Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant.

Baseline delta sleep ratio predicts acute ketamine mood response in major depressive disorder ⬇️

Baseline working memory activation deficits in dimensional anxious depression as detected by magnetoencephalography ⬇️

Biomarkers in mood disorders research: developing new and improved therapeutics

Brain-derived neurotrophic factor Val66Met polymorphism and antidepressant efficacy of ketamine in depressed patients.

Brain-derived neurotrophic factor and initial antidepressant response to an N-methyl-D-aspartate antagonist.

Clinical predictors of ketamine response in treatment-resistant major depression

Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder

Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study

D-serine plasma concentration is a potential biomarker of (R,S)-ketamine antidepressant response in subjects with treatment-resistant depression

Default Mode Connectivity in Major Depressive Disorder Measured Up to 10 Days After Ketamine Administration

Defining anxious depression: a review of the literature.

Developing biomarkers in mood disorders research through the use of rapid-acting antidepressants

Do the dissociative side effects of ketamine mediate its antidepressant effects?

Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine.

Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study

Family history of alcohol dependence and antidepressant response to an N‐methyl‐D‐aspartate antagonist in bipolar depression ⬇️

Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonist

Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression.

Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder

Glutamatergic modulators: the future of treating mood disorders?

Histone deacetylases and mood disorders: epigenetic programming in gene-environment interactions

Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety.

Increased fear-potentiated startle in major depressive disorder patients with lifetime history of suicide attempt

Ketamine's antidepressant efficacy is extended for at least four weeks in subjects with a family history of an alcohol use disorder.

Lithium and Valproate Levels Do Not Correlate with Ketamine's Antidepressant Efficacy in Treatment-Resistant Bipolar Depression

Major Depression Is Not Associated with Blunting of Aversive Responses; Evidence for Enhanced Anxious Anticipation ⬇️

Motor-Activity Markers of Circadian Timekeeping Are Related to Ketamine's Rapid Antidepressant Properties

NEUROBIOLOGICAL ASPECTS OF SUICIDE AND SUICIDE ATTEMPTS IN BIPOLAR DISORDER.

Neural correlates of rapid antidepressant response to ketamine in bipolar disorder.

Neural correlates of rapid antidepressant response to ketamine in treatment-resistant unipolar depression: a preliminary positron emission tomography study.

Neurobiology of anxious depression: a review

New therapeutic targets for mood disorders

Novel glutamatergic agents for major depressive disorder and bipolar disorder

Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effects

Pharmacologic treatment of dimensional anxious depression: a review

Pramipexole for bipolar II depression: a placebo-controlled proof of concept study

Protein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorder

Rapid antidepressant changes with sleep deprivation in major depressive disorder are associated with changes in vascular endothelial growth factor (VEGF): a pilot study

Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression

Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder

Rating depression over brief time intervals with the Hamilton Depression Rating Scale: standard vs. abbreviated scales

Recognition of emotional facial expressions in anxious and nonanxious depression.

Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression

Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial

Riluzole likely lacks antidepressant efficacy in ketamine non-responders.

Second messenger/signal transduction pathways in major mood disorders: moving from membrane to mechanism of action, part I: major depressive disorder.

Second messenger/signal transduction pathways in major mood disorders: moving from membrane to mechanism of action, part II: bipolar disorder

Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression

Subanesthetic Dose Ketamine Does Not Induce an Affective Switch in Three Independent Samples of Treatment-Resistant Major Depression ⬇️

Synaptic Potentiation Is Critical for Rapid Antidepressant Response to Ketamine in Treatment-Resistant Major Depression ⬇️

Targeting glutamatergic signaling for the development of novel therapeutics for mood disorders

The McLean-Harvard First-Episode Mania Study: Prediction of Recovery and First Recurrence

The Neurobiology of the Switch Process in Bipolar Disorder